Literature DB >> 19822889

Dengue virus pathogenesis: an integrated view.

Byron E E Martina1, Penelope Koraka, Albert D M E Osterhaus.   

Abstract

Much remains to be learned about the pathogenesis of the different manifestations of dengue virus (DENV) infections in humans. They may range from subclinical infection to dengue fever, dengue hemorrhagic fever (DHF), and eventually dengue shock syndrome (DSS). As both cell tropism and tissue tropism of DENV are considered major determinants in the pathogenesis of dengue, there is a critical need for adequate tropism assays, animal models, and human autopsy data. More than 50 years of research on dengue has resulted in a host of literature, which strongly suggests that the pathogenesis of DHF and DSS involves viral virulence factors and detrimental host responses, collectively resulting in abnormal hemostasis and increased vascular permeability. Differential targeting of specific vascular beds is likely to trigger the localized vascular hyperpermeability underlying DSS. A personalized approach to the study of pathogenesis will elucidate the basis of individual risk for development of DHF and DSS as well as identify the genetic and environmental bases for differences in risk for development of severe disease.

Entities:  

Mesh:

Year:  2009        PMID: 19822889      PMCID: PMC2772360          DOI: 10.1128/CMR.00035-09

Source DB:  PubMed          Journal:  Clin Microbiol Rev        ISSN: 0893-8512            Impact factor:   26.132


  269 in total

1.  Strong HLA class I--restricted T cell responses in dengue hemorrhagic fever: a double-edged sword?

Authors:  H Loke; D B Bethell; C X Phuong; M Dung; J Schneider; N J White; N P Day; J Farrar; A V Hill
Journal:  J Infect Dis       Date:  2001-11-13       Impact factor: 5.226

2.  Influence of the dengue serotype, previous dengue infection, and plasma viral load on clinical presentation and outcome during a dengue-2 and dengue-4 co-epidemic.

Authors:  Laurent Thomas; Olivier Verlaeten; André Cabié; Stéphane Kaidomar; Victor Moravie; Jenny Martial; Fatiha Najioullah; Yves Plumelle; Christiane Fonteau; Philippe Dussart; Raymond Césaire
Journal:  Am J Trop Med Hyg       Date:  2008-06       Impact factor: 2.345

3.  Retrospective study on dengue fatal cases.

Authors:  M P Miagostovich; R G Ramos; A F Nicol; R M Nogueira; T Cuzzi-Maya; A V Oliveira; R S Marchevsky; R P Mesquita; H G Schatzmayr
Journal:  Clin Neuropathol       Date:  1997 Jul-Aug       Impact factor: 1.368

4.  Anti-TNF antibody treatment reduces mortality in experimental dengue virus infection.

Authors:  Alena Atrasheuskaya; Peter Petzelbauer; Terry M Fredeking; George Ignatyev
Journal:  FEMS Immunol Med Microbiol       Date:  2003-01-21

5.  Severe dengue virus infection in travelers: risk factors and laboratory indicators.

Authors:  Ole Wichmann; Joaquim Gascon; Mirjam Schunk; Sabino Puente; Heli Siikamaki; Ida Gjørup; Rogelio Lopez-Velez; Joannes Clerinx; Gabriele Peyerl-Hoffmann; Anders Sundøy; Blaise Genton; Peter Kern; Guido Calleri; Miguel de Górgolas; Nikolai Mühlberger; Tomas Jelinek
Journal:  J Infect Dis       Date:  2007-03-02       Impact factor: 5.226

6.  Phenotyping of peripheral blood mononuclear cells during acute dengue illness demonstrates infection and increased activation of monocytes in severe cases compared to classic dengue fever.

Authors:  Anna P Durbin; Maria José Vargas; Kimberli Wanionek; Samantha N Hammond; Aubree Gordon; Crisanta Rocha; Angel Balmaseda; Eva Harris
Journal:  Virology       Date:  2008-05-02       Impact factor: 3.616

7.  Liver injury caused by antibodies against dengue virus nonstructural protein 1 in a murine model.

Authors:  Chiou-Feng Lin; Shu-Wen Wan; Mei-Chun Chen; Shin-Chao Lin; Chu-Chen Cheng; Shu-Chen Chiu; Yu-Ling Hsiao; Huan-Yao Lei; Hsiao-Sheng Liu; Trai-Ming Yeh; Yee-Shin Lin
Journal:  Lab Invest       Date:  2008-08-04       Impact factor: 5.662

8.  Development of cross-reactive antibodies to plasminogen during the immune response to dengue virus infection.

Authors:  L J Markoff; B L Innis; R Houghten; L S Henchal
Journal:  J Infect Dis       Date:  1991-08       Impact factor: 5.226

9.  Antibody-dependent enhancement of Murray Valley encephalitis virus virulence in mice.

Authors:  M J Wallace; D W Smith; A K Broom; J S Mackenzie; R A Hall; G R Shellam; P C McMinn
Journal:  J Gen Virol       Date:  2003-07       Impact factor: 3.891

10.  Facilitation of cell adhesion by immobilized dengue viral nonstructural protein 1 (NS1): arginine-glycine-aspartic acid structural mimicry within the dengue viral NS1 antigen.

Authors:  Hsin-Hou Chang; Huey-Fen Shyu; Yo-Ming Wang; Der-Shan Sun; Rong-Hwa Shyu; Shiao-Shek Tang; Yao-Shine Huang
Journal:  J Infect Dis       Date:  2002-08-28       Impact factor: 5.226

View more
  291 in total

1.  A lethal murine infection model for dengue virus 3 in AG129 mice deficient in type I and II interferon receptors leads to systemic disease.

Authors:  Vanessa V Sarathy; Mellodee White; Li Li; Summer R Gorder; Richard B Pyles; Gerald A Campbell; Gregg N Milligan; Nigel Bourne; Alan D T Barrett
Journal:  J Virol       Date:  2014-11-12       Impact factor: 5.103

2.  A three-component biomarker panel for prediction of dengue hemorrhagic fever.

Authors:  Allan R Brasier; Hyunsu Ju; Josefina Garcia; Heidi M Spratt; Sundar S Victor; Brett M Forshey; Eric S Halsey; Guillermo Comach; Gloria Sierra; Patrick J Blair; Claudio Rocha; Amy C Morrison; Thomas W Scott; Isabel Bazan; Tadeusz J Kochel
Journal:  Am J Trop Med Hyg       Date:  2012-02       Impact factor: 2.345

Review 3.  Staphylococcus aureus pneumonia and dengue virus co-infection and review of implications of coinfection.

Authors:  Rajeev Peeyush Nagassar; Roma Jaanki Bridgelal-Nagassar; Nathlee McMorris; Nathalie Mc Morris; Karen Judith Roye-Green
Journal:  BMJ Case Rep       Date:  2012-07-03

4.  Relationship between nonstructural protein 1 detection and plasma virus load in Dengue patients.

Authors:  Laurent Thomas; Fatiha Najioullah; Olivier Verlaeten; Jenny Martial; Ségolène Brichler; Stéphane Kaidomar; Victor Moravie; André Cabié; Raymond Césaire
Journal:  Am J Trop Med Hyg       Date:  2010-09       Impact factor: 2.345

Review 5.  Dengue epidemiology and pathogenesis: images of the future viewed through a mirror of the past.

Authors:  Rashedul Islam; Mohammed Salahuddin; Md Salahuddin Ayubi; Tahmina Hossain; Apurba Majumder; Andrew W Taylor-Robinson; Abdullah Mahmud-Al-Rafat
Journal:  Virol Sin       Date:  2015-10-20       Impact factor: 4.327

6.  Altered profile of regulatory T cells and associated cytokines in mild and moderate dengue.

Authors:  H Tillu; A S Tripathy; P V Reshmi; D Cecilia
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2016-02-09       Impact factor: 3.267

7.  Molecular classification of outcomes from dengue virus -3 infections.

Authors:  Allan R Brasier; Yingxin Zhao; John E Wiktorowicz; Heidi M Spratt; Eduardo J M Nascimento; Marli T Cordeiro; Kizhake V Soman; Hyunsu Ju; Adrian Recinos; Susan Stafford; Zheng Wu; Ernesto T A Marques; Nikos Vasilakis
Journal:  J Clin Virol       Date:  2015-01-17       Impact factor: 3.168

8.  High-content assay to identify inhibitors of dengue virus infection.

Authors:  David Shum; Jessica L Smith; Alec J Hirsch; Bhavneet Bhinder; Constantin Radu; David A Stein; Jay A Nelson; Klaus Früh; Hakim Djaballah
Journal:  Assay Drug Dev Technol       Date:  2010-10       Impact factor: 1.738

9.  A Cyclic Phosphoramidate Prodrug of 2'-Deoxy-2'-Fluoro-2'-C-Methylguanosine for the Treatment of Dengue Virus Infection.

Authors:  Ratna Karuna; Fumiaki Yokokawa; Keshi Wang; Jin Zhang; Haoying Xu; Gang Wang; Mei Ding; Wai Ling Chan; Nahdiyah Abdul Ghafar; Andrea Leonardi; Cheah Chen Seh; Peck Gee Seah; Wei Liu; Rao P S Srinivasa; Siew Pheng Lim; Suresh B Lakshminarayana; Ellie Growcott; Sreehari Babu; Martijn Fenaux; Weidong Zhong; Feng Gu; Pei-Yong Shi; Francesca Blasco; Yen-Liang Chen
Journal:  Antimicrob Agents Chemother       Date:  2020-11-17       Impact factor: 5.191

10.  The cytokine response of U937-derived macrophages infected through antibody-dependent enhancement of dengue virus disrupts cell apical-junction complexes and increases vascular permeability.

Authors:  Henry Puerta-Guardo; Arturo Raya-Sandino; Lorenza González-Mariscal; Victor H Rosales; José Ayala-Dávila; Bibiana Chávez-Mungía; Daniel Martínez-Fong; Fernando Medina; Juan E Ludert; Rosa María del Angel
Journal:  J Virol       Date:  2013-04-24       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.